PPP1R12A-AS1: A Potential Drug Target and Biomarker (G105369865)

Target Name: PPP1R12A-AS1

NCBI ID: G105369865

PPP1R12A-AS1

Other Name(s): PPP1R12A antisense RNA 1 | R12A-AS1 | PPP1R12A-AS1 variant 1 | PPP1R12A antisense RNA 1, transcript variant 1

PPP1R12A-AS1: A Potential Drug Target and Biomarker

PPP1R12A-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to be involved in the regulation of cell proliferation and survival. recent studies have suggested that PPP1R12A-AS1 may have potential as a drug target and biomarker.

The protein PPP1R12A-AS1 is a member of the PPP1R family, which is known to be involved in the regulation of protein synthesis. PPP1R12A-AS1 is expressed in the brain and other tissues and has been shown to be involved in the regulation of neuronal excitability and synaptic plasticity.

One of the potential benefits of targeting PPP1R12A-AS1 as a drug target is its potential to modulate the activity of neurons and other cells in the brain. This could potentially lead to therapeutic benefits for a variety of neurological and psychiatric disorders. For example, PPP1R12A-AS1 has been shown to play a role in the regulation of neurotransmitter release and cell survival, which could make it a potential target for treatments for disorders such as depression, anxiety, and neurodegenerative diseases.

In addition to its potential as a drug target, PPP1R12A-AS1 has also been suggested as a potential biomarker for certain diseases. The regulation of PPP1R12A-AS1 has been shown to be involved in a variety of physiological processes, including cell growth, differentiation, and survival. This suggests that changes in PPP1R12A-AS1 expression levels could be a potential indicator of certain diseases. For example, decreased PPP1R12A-AS1 expression has been shown to be associated with cancer, and increased PPP1R12A-AS1 expression has been linked to neurodegenerative diseases.

Another potential benefit of targeting PPP1R12A-AS1 as a drug target is its potential to modulate the activity of immune cells. PPP1R12A-AS1 has been shown to play a role in the regulation of immune cell function and has been implicated in the development of autoimmune diseases. Targeting PPP1R12A-AS1 as a drug target could potentially lead to therapeutic benefits for autoimmune disorders.

In conclusion, PPP1R12A-AS1 is a protein that has been shown to be involved in the regulation of various physiological processes in the body. Its potential as a drug target and biomarker make it an attractive target for future research and clinical development. Further studies are needed to fully understand the function of PPP1R12A-AS1 and its potential as a drug and biomarker.

Protein Name: PPP1R12A Antisense RNA 1

The "PPP1R12A-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP1R12A-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets